Author

Fernando Muñoz 1

1 Hospital Universitario de Salamanca,Salamanca,Spain

Clinical features, therapeutic requirements and evolution of patients with Crohn´s disease and upper digestive tract involvement (CROHNEX study)

Empar Sainz Arnau, Yamile Zabana, Isabel Miguel, Agnes Fernandez Clotet, Maria José Casanova, Maria Dolores Martín, Maria Dolores Picó, Erika Alfambra, Iago Rodríguez, Fernando Muñoz, Manuel Domínguez, Eva Iglesias, David Busquets, Ana Gutiérrez, Fiorella Cañete, Laura Núñez, Carlos Taxonera, Belen Beltran, Blau Camps, Xavier Calvet, Pablo Navarro, Margalida Calafat, Rocío Ferreiro-Iglesias, Carlos Gonzalez Muñoza, Beatriz Sicilia, Cristina Rodriguez, Ana Y. Carbajo, Manuel Van Domselaar, Raquel Vicente, Marta Piqueras, Mari Carmen Muñoz, Agueda Abad La Cruz, Alicia Algaba, Pilar Martinez, Milagros Vela, Beatriz Antolín, José María Huguet, Luis Bujanda, Rufo H. Lorente, Pedro Almela, Maria Jose Garcia, Patricia Ramírez de la Pirscina, Ramón Pajares, Isabel Pérez-Martínez, Alfredo J. Lucendo, Olga Merino, Jesús Legido, Isabel Vera, Victor Jair Morales, María Esteve

OBSERVATIONAL STUDY ON THE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN AN ULCERATIVE COLITIS POPULATION COMPRISED BY BIO-NAÏVE PATIENTS AND PATIENTS WITH FAILURE OF ONE PREVIOUS ANTI-TNF (EVOLVE-IB STUDY)

Francisco Casellas, Cristina Rodriguez, Claudia Herrera de Guise, Javier Pérez Gisbert, Isabel Vera Mendoza, María Dolores Martín-Arranz, Sabino Riestra, Pilar Martínez-Montiel, Vanesa Royo, Patricia Suárez, Esther García-Planella, Orlando Garcia-Bosch, Marisa Iborra, Ana Gutierrez Casbas, Jesus Aparicio, Alonso Fernandez-Ni

PERFORMANCE OF SCREENING STRATEGIES FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY OF GETECCU

Sabino Riestra, Javier Gisbert, Carlos Taxonera, Antonio López-Sanromán, Jesús Barrio, Maria Chaparro, Yamile Zabana, Daniel Carpio López, Montserrat Rivero, Ruth De Francisco, María Esteve, Pilar Nos, Santiago García López, Miriam Mañosa, José Lázaro Pérez-Calle, Jordi Guardiola, Fernando Muñoz, María Dolores Martín-Arran

REAL WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN CROHN'S DISEASE WHEN USED AS A FIRST BIOLOGIC OR AFTER FAILURE OF ONE PREVIOUS ANTI-TNF (EVOLVE-IB STUDY)

Fernando Muñoz

REAL WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN CROHN’S DISEASE WHEN USED AS A FIRST BIOLOGIC OR AFTER FAILURE OF ONE PREVIOUS ANTI-TNF (EVOLVE-IB STUDY)

Fernando Muñoz, Cristina Rodriguez, Javier Pérez Gisbert, Claudia Herrera de Guise, Isabel Vera Mendoza, Ana Gutierrez Casbas, María Dolores Martín-Arranz, Pilar Martínez-Montiel, Vanesa Royo, Patricia Suárez, Esther García-Planella, Orlando Garcia-Bosch, Marisa Iborra, Jesus Aparicio, Ignacio Tagarro, Alonso Fernandez-Nista

Item 1 - 5 / 5
1